舒血宁联合奥扎格雷钠治疗急性脑梗死80例报告

目的探讨舒血宁联合奥扎格雷钠静点治疗急性脑梗死的临床疗效。方法将80例脑梗死病人随机分成对照组和治疗组,对照组40例给以奥扎格雷钠80mg加入生理盐水中静滴,每日1次,治疗组在对照组基础上加用舒血宁20ml加入生理盐水中静点,每日1次。结果治疗组有效率80%,显著高于对照组(P<0.05),且未发现有严重的肝肾功能损害及出血等不良反应。结论舒血宁与奥扎格雷钠联合治疗急性脑梗死安全有效,疗效优于单用奥扎格雷钠。

Objective To investigate the clinical efficacy of ozagrel combined with shuxuening in treating 80 cases of acute cerebral infarction patients. Methods 80 patients with cerebral infarction were randomly divided into control group and treatment group. 40 patients in the control group are given 80 mg ozagrel infusion of normal saline once a day. Based on the control group the treatment group was treated with shuxuening by adding 20ml normal saline intravenous. Results Effective rate of treatment group was 80%, and it was significantly higher than the control group （P0.05）. The treatment group did not have serious liver and kidney damage and bleeding and other adverse reactions. Conclusion Shuxuening combined with ozagrel in treatment of acute cerebral infarction is safe and effective, more effective than single-use ozagrel.